More importantly, we used functional assay and found that PAXIP1-AS1 attenuated EMT and the motility of GC cells, whereas PABPC1 reversed PAXIP1-AS1-induced EMT inhibition and the invasive and migratory abilities of GC cells. Here, PABPC1 is linked to gastric cancer.